|
시장보고서
상품코드
2091406
천장관절염 치료 시장 규모, 점유율, 성장 분석 : 치료법별, 진단 방법별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Sacroiliitis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Medications, Physical Therapy), By Diagnosis Method (Imaging Studies, Physical Examination), By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 천장관절염 치료 시장 규모는 2024년에 4억 5,000만 달러로 평가되었으며, 2025년 4억 8,150만 달러에서 2033년까지 9억 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 7.0%로 성장할 것으로 전망됩니다.
세계 천장관절염 치료 시장의 성장은 주로 사이토카인 경로를 표적으로 하는 생물학적 제제 요법의 발전에 힘입어 이루어지고 있습니다. 임상의들은 바이오마커 데이터를 활용해 치료를 개인화하는 경향이 강해지고 있으며, 섹티니맙과 같은 효과적인 약물을 환자에게 적절히 처방함으로써 증상 완화를 촉진하고 수술률을 낮추고 있습니다. 이러한 성공에 힘입어 각 제약사는 혁신적인 파이프라인 후보에 대한 투자를 적극적으로 추진하고 있는 반면, 보험사는 검증된 치료법을 우선시하는 단계적 보험 적용 제도를 도입하는 등 대응을 강화하고 있습니다. 그 결과, 병원 내에는 류마티스학과, 방사선과, 물리치료과를 통합한 다직종 협력 클리닉이 설립되었으며, 이를 통해 새로운 수익 기회가 창출될 뿐만 아니라 환자의 치료 순응도도 향상되고 있습니다. 전반적으로, 전 세계 보험사들의 수용 확대와 공동 연구 이니셔티브에 힘입어 이 시장은 연평균 성장률(CAGR) 12%를 기록할 것으로 예상됩니다.
세계 천장관절염 치료 시장의 성장요인
세계 천장관절염 치료 시장은 이 질환의 증상에 대한 임상의들의 인식이 높아짐에 따라 전용 교육 이니셔티브를 통해 크게 성장하고 있습니다. 이러한 지식의 향상을 통해 환자의 조기 의뢰가 활성화되고, 다양한 치료 옵션에 대한 수용도가 높아지고 있습니다. 의사들이 질환 경과 조절 치료를 고려하는 경향이 강해짐에 따라, 환자들 역시 전문적인 치료를 요구하는 경향이 강해지고 있습니다. 또한, 혁신적인 치료법이 표준 진료에 도입됨에 따라 시장 전체의 수요가 확대되고 있습니다. 공동 조사 활동은 치료법의 유효성을 한층 더 입증함으로써, 임상의들의 신뢰를 높이고 환자들의 수용을 촉진하여, 궁극적으로 각 지역의 지속가능한 성장에 기여하고 있습니다.
세계 천장관절염 치료 시장의 제약요인
세계 천장관절염 치료 시장은 치료에 수반되는 고액의 비용이라는 큰 과제에 직면해 있습니다. 이러한 높은 비용으로 인해, 많은 의료 제도와 경제적 제약으로 인해 더 저렴한 대안을 선택할 수밖에 없는 환자들의 접근이 제한되고 있습니다. 이러한 경제적 부담으로 인해 의료 제공자는 고가의 치료법을 권장하는 것을 주저하게 되고, 보험사는 엄격한 보상 기준을 적용하게 됩니다. 그 결과, 환자들이 치료법을 채택하는 데 차질이 생겨 시장 확대가 주춤하고 있습니다. 그 결과, 제조업체들은 가격에 대한 민감성에 대응할 수밖에 없게 되어, 이익률을 낮추고 지속가능한 성장을 저해할 가능성이 있는 할인 전략을 빈번히 시행하고 있습니다. 이러한 가격 책정상의 장벽은 연구개발에 대한 투자도 저해하며, 결과적으로 혁신적인 치료법의 등장을 제한하게 됩니다.
세계 천장관절염 치료 시장의 동향
세계 천장관절염 치료 시장은 정밀 영상 진단 기술의 보급에 따라 큰 변화를 겪고 있습니다. 고해상도 근골격계 영상 진단 기술의 발전으로 진단 정확도가 향상되고, 천장관절염의 조기 발견이 가능해짐에 따라, 임상의들은 질환의 병기를 보다 정확하게 판정할 수 있게 되었습니다. 또한, 자기공명영상(MRI) 기술과 정량적 바이오마커의 활용이 확대됨에 따라 염증성 변화와 변성성 변화를 구별하기가 쉬워졌으며, 침습적인 진단 조치의 필요성이 최소화되고 있습니다. 이러한 영상 진단 기술의 보급이 확대되고, 보험 환급 모델도 이에 맞춰 조정됨에 따라 의료 서비스 제공자들은 정밀 진단을 표준 진료 과정에 포함시키고 있으며, 그 결과 전 세계적으로 관련 영상 진단 서비스 및 맞춤형 치료 전략에 대한 수요가 증가하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 천장관절염 치료 시장 규모 : 치료 유형별
세계의 천장관절염 치료 시장 규모 : 진단 방법별
세계의 천장관절염 치료 시장 규모 : 최종사용자별
세계의 천장관절염 치료 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.07.23Global Sacroiliitis Treatment Market size was valued at USD 450.0 Million in 2024 and is poised to grow from USD 481.5 Million in 2025 to USD 900.0 Million by 2033, growing at a CAGR of 7.0% during the forecast period (2026-2033).
The growth of the global sacroiliitis treatment market is primarily fueled by advances in biologic therapies targeting cytokine pathways. Clinicians are increasingly utilizing biomarker data to personalize treatment, matching patients with effective agents like secukinumab, which enhances symptom relief and reduces surgery rates. This success motivates pharmaceutical companies to invest in innovative pipeline candidates, while insurance providers are adapting by offering tiered coverage that prioritizes proven therapies. As a result, hospitals are establishing multidisciplinary clinics that integrate rheumatology, radiology, and physical therapy, thus creating new revenue opportunities and improving patient adherence. Overall, the market is expected to experience a compound annual growth rate of 12 percent, bolstered by wider payer acceptance and collaborative research initiatives across the globe.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sacroiliitis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Sacroiliitis Treatment Market Segments Analysis
Global sacroiliitis treatment market is segmented by treatment type, diagnosis method, end user and region. Based on treatment type, the market is segmented into Medications, Physical Therapy, Radiofrequency Ablation, Sacroiliac Joint Injections and Surgical Fusion. Based on diagnosis method, the market is segmented into Imaging Studies, Physical Examination and Laboratory Tests. Based on end user, the market is segmented into Hospitals, Orthopedic Clinics and Rheumatology Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Sacroiliitis Treatment Market
The global market for sacroiliitis treatment is being significantly bolstered by an increase in clinician awareness regarding the symptoms of this condition, driven by dedicated educational initiatives. This enhanced knowledge leads to earlier patient referrals and a greater acceptance of diverse therapeutic options. As physicians become more inclined to consider disease-modifying treatments, patients are also more likely to seek specialized care. Additionally, the incorporation of innovative treatment modalities into standard practices is widening overall market demand. Collaborative research efforts further support treatment validation, reinforcing clinician confidence and encouraging patient acceptance, ultimately contributing to sustained growth across various regions.
Restraints in the Global Sacroiliitis Treatment Market
The Global Sacroiliitis Treatment market faces significant challenges due to the high costs associated with treatment, which restrict access for numerous healthcare systems and patients operating under financial constraints that favor cheaper alternatives. This economic burden discourages healthcare providers from recommending high-end therapies and leads payers to enforce strict reimbursement criteria, ultimately hindering patient adoption and slowing market expansion. As a result, manufacturers are compelled to address price sensitivity, frequently implementing discount strategies that may diminish profit margins and hinder sustainable growth. These pricing obstacles also impede investment in research and development, thereby limiting the emergence of innovative treatment options.
Market Trends of the Global Sacroiliitis Treatment Market
The Global Sacroiliitis Treatment market is undergoing significant transformation shaped by the rising adoption of precision imaging technologies. High-resolution musculoskeletal imaging advancements are enhancing diagnostic accuracy and enabling earlier detection of sacroiliitis, allowing clinicians to better stage the disease. Increasingly, magnetic resonance imaging techniques and the use of quantitative biomarkers are facilitating the differentiation between inflammatory and degenerative changes, minimizing the need for invasive diagnostic procedures. As these imaging technologies become more prevalent and reimbursement models adapt to support them, healthcare providers are integrating precision diagnostics in standard practices, consequently driving the demand for related imaging services and tailored therapeutic strategies worldwide.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Sacroiliitis Treatment Market Size by Treatment Type & CAGR (2026-2033)
- Market Overview
- Medications
- Physical Therapy
- Radiofrequency Ablation
- Sacroiliac Joint Injections
- Surgical Fusion
Global Sacroiliitis Treatment Market Size by Diagnosis Method & CAGR (2026-2033)
- Market Overview
- Imaging Studies
- Physical Examination
- Laboratory Tests
Global Sacroiliitis Treatment Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Orthopedic Clinics
- Rheumatology Clinics
Global Sacroiliitis Treatment Market Size & CAGR (2026-2033)
- North America (Treatment Type, Diagnosis Method, End User)
- US
- Canada
- Europe (Treatment Type, Diagnosis Method, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Treatment Type, Diagnosis Method, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Treatment Type, Diagnosis Method, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Treatment Type, Diagnosis Method, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Haemonetics Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wright Medical Group NV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zyga Technology Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NuTech Medical Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CoorsTek Medical LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medacta International SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aspen Medical Products LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cooper Companies Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DePuy Synthes Companies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Xtant Medical Holdings Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Camber Spine Technologies LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CariCarba Spine Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inspire Medical Systems Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RTI Surgical Holdings Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wright Medical Group NV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fresenius Medical Care AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NView Medical Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Convatec Group plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vertos Medical Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
